Providing quality healthcare to all is a key challenge for the Government of India. Standard treatment guidelines (STGs), alternatively known as standard treatment schedules, standard treatment protocols or therapeutic guidelines, are systematically developed statements which are designed to assist practitioners and patients in making informed decisions about suitable healthcare for specific clinical conditions. These include the preferred pharmaceutical and non-pharmaceutical treatments for common health problems came across by people in a specific health system[@ref1]. These STGs are used worldwide to prevent the misuse of medicines through the improper treatment of common problems and to encourage the economically efficient and therapeutically effective usage of medicines[@ref2]. The rising cost of healthcare, differences in clinical practice among providers and hospitals, and problems faced by prescribers in keeping themselves up-to-date with fast-growing new scientific evidence, especially in places with limited resources, have increased interest in, and the importance of STGs.

Experience and studies have shown that there could be ineffective, unsafe, or wasteful prescribing, even when the drugs supply is based on an approved formulary or essential medicines list. It is falsely believed that STGs bring constraints to prescribing[@ref3]. STGs only advise prescribers, who still retain the power and responsibility to make decisions about appropriate treatments for their patients, and define the boundaries between the accepted norms in treating a disease, based on clinical evidence and the practice of relying purely on clinical experience[@ref3].

Sharma *et al*[@ref2] have noted that while some fruitful approaches to developing STGs have been well documented in India, multiple clinical practice guidelines continue to be produced by insurers, professional organizations, individuals, and others. While the quality of the STGs produced has not been assessed systematically, these are reported to be of poor quality or content or conflict with each other, failing to inspire confidence in prescribers. The development of STGs is a complex and lengthy process, and has its own risks. Because of their non-binding nature, there is a risk that these guidelines will not be accepted by clinicians[@ref2][@ref4]. The creation of effective guidelines needs robust development, strong editorial and project management processes, along with a keen eye for details about various sections of the guidelines[@ref2].

The aim of this study was to conduct a systematic review of STGs available in India to evaluate if recommendations for STGs by World Health Organization (WHO) are fulfilled. The secondary objective was to compare the manner in which STGs are framed in India with more established processes in the UK and USA.

Material & Methods {#sec1-2}
==================

*Search strategy:* The inclusion criteria were published articles in the English language which mentioned STGs in India. \'Standard Treatment Guidelines AND India\' were the keywords used for the search strategy. A systematic literature search was conducted till March 2016, in two major databases namely, PubMed and Google Scholar. The PRISMA guidelines and Cochrane handbook for systematic reviews provided a framework for the reporting structure of this systematic review[@ref4][@ref5]. The focus of the search was to retrieve STGs mentioned in scholarly articles and in related Google searches. Google search was also done to find any relevant STGs which might not be found in published journal articles. Non-peer reviewed journals were also included in the search as many of the STGs in India are published on either government websites or non-peer reviewed journals. A manual search was also done in references list of the retrieved publications for other publications that might fulfil the study inclusion criteria. The authors of the shortlisted publications (whose emails were available in the publication or on the internet) were contacted by email to pursue their advice on other publications related to our research question, allowing one-month time for them to reply.

[Screening process for inclusion]{.ul}: The results were restricted to studies on human subjects. Only STGs that were available online were included. At each stage, two independent reviewers assessed the publications for the inclusion criteria. Publications about non-Indian STGs were excluded.

[Assessment of published reports/studies]{.ul}: The STGs obtained from the refined search were reviewed for analysis and to capture the information on the variables of interest (WHO and authors\' criteria) in a spreadsheet. The extraction of data was done and entries were checked. Multiple STGs available from a single source were counted as a single STG and not as multiple.

The WHO criteria[@ref1][@ref6] were: condition for which the STG was developed, STG was for a single disease or multi-diseases, presence of diagnostic criteria, treatment objectives, non-drug treatment, drug/ treatment of choice, 2^nd^ or 3^rd^ line of treatment with indications. Prescribing information, patient referral criteria, patient education regarding the condition and the cost of treatments, especially if alternatives were proposed.

Authors\' criteria were: name, year of publication, and edition of the STG, number of years after which STGs were revised, whether management algorithm was given, was the STG evidence-based, development authority of the STG, whether STG was part of a national programme and did the STG have specific guidelines for primary, secondary and tertiary levels.

In the Indian context, since the dose recommended (variation due to genetic and environmental factors, nutrition, and body weight) as well as the drug of choice (due to resistant microbes) may be different, evidence from Indian studies would be important. Hence, references were scrutinized and if all references were Indian studies, it was considered as entirely Indian evidence-based STG, and if references were Indian plus international studies, it was considered partially Indian evidence-based.

Methodology used for extracting information on the legal authority and responsibility for developing STGs: this information was retrieved by means of a Google search for terms such as \'STGs in India\' and \'clinical guidelines in the UK\'. In addition, the text of the Indian Clinical Establishments (Registration and Regulation) Act 2010[@ref7] was scrutinized for its provisions on STGs. The websites of the National Health Mission (NHM) and National Institute for Health and Care Excellence (NICE) were surveyed to find out the authority vested with this responsibility and to understand how STGs in India and the UK are framed and disseminated[@ref8][@ref9][@ref10][@ref11]. Lastly, a number of decisions of courts in India and in the UK that were available on case law databases such as Manupatra and Westlaw, or were referred to in the journal articles were searched. The search words used to find these decisions included \'clinical guidelines\', \'STGs\' and \'medical practitioners are bound\'. The type of STGs and the authority that they hold over the conduct of medical practitioners were analysed under these decisions by the courts in India.

Results {#sec1-3}
=======

The search strategy identified 1695 results through PubMed and Google Scholar search. After removing the duplicates (n=225), the inclusion criteria were applied to 1470 publications that were searched manually. Fifty six full text articles were read from which 27 different STGs were selected ([Fig. 1](#F1){ref-type="fig"}).
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A total of 35 emails were sent to the authors, of whom 14 replied. Of these 14, two authors provided further information about six publications, three of which dealt with International STGs, one provided information about an STG already included in the study and two about STGs that were not on our list and were therefore, included in the study. While conducting a Google search for the STGs found in the publications, 34 STGs were found. Finally, 63 different STGs were included. Of these, only three were published in 2015 and 13 in 2014. The remaining 45 guidelines were published in 2012 or earlier. The oldest STG in the list was published in 1999 and was never revised after that. Two STGs did not mention the year of publication.

Forty eight STGs were for a single disease and the rest were for multiple conditions; 55 STGs did not include specific treatment according to levels of healthcare, one each had treatment specific for primary, secondary and tertiary levels of healthcare respectively, and six STGs were for all three levels of healthcare. None of the STGs were updated at regular intervals.

While analysing evidence base it was noted that of the 63 STGs, eight gave no references while 55 provided international and Indian references (partial Indian) ([Fig. 2](#F2){ref-type="fig"}). There was no uniformity in the format regarding STGs in India. This was in contrast with clinical guidelines in the UK developed by NICE, which met all WHO recommendations. One of the reasons for this might be the fact that India has not yet put in place a systematic process for the development of STGs as NICE. The legal framework governing the development of STGs in India is described below, and compared with the process in the UK ([Table I](#T1){ref-type="table"}).

![Number of standard treatment guidelines (STGs) fulfilling World Health Organization and authors\' criteria.](IJMR-149-715-g002){#F2}

###### 

List of standard treatment guidelines (STGs) with details of year, edition, publication, authority and conditions included in the STGs

  Name of the STG                                                                                                                                                                  Year   Edition         Comes under/developed by                                                                                          Scope of guidelines
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------ --------------- ----------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------
  Consensus Guidelines on Management of Childhood Asthma in India[@ref12]                                                                                                          1999   NM              Expert consensus                                                                                                  Childhood asthma
  Guidelines for Management of Asthma at Primary and Secondary Levels of Health Care in India (2005)[@ref13]                                                                       2005   NM              WHO and Government of India Collaborative Programme                                                               Bronchial asthma
  Best Treatment Guidelines For Bronchial Asthma[@ref14]                                                                                                                           2007   NM              Update article by authors                                                                                         Bronchial asthma
  Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations[@ref15]                                                                          2015   NM              Indian Chest Society and National College of Chest Physicians                                                     Bronchial asthma
                                                                                                                                                                                                                                                                                                                            
  **Diabetes**                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                            
  Guidelines for Management of Type 2 Diabetes[@ref16]                                                                                                                             2005   1^st^           ICMR, WHO                                                                                                         Type 2 diabetes
  API-ICP Guidelines on Diabetes 2007[@ref17]                                                                                                                                      2007   NM              API-ICP                                                                                                           Diabetes
  Guidelines for the Comprehensive Management of Diabetic Retinopathy in India[@ref18]                                                                                             2008   NM              Aravind eye care system                                                                                           Diabetic retinopathy
  Premix insulin: Initiation and Continuation Guidelines for Management of Diabetes in Primary Care[@ref19]                                                                        2009   1^st^           API                                                                                                               Diabetes
  Type 1 Diabetes Mellitus in Children and Adolescents In India Clinical Practice Guidelines 2011[@ref20]                                                                          2011   1^st^           ISPAE                                                                                                             Type 1 diabetes mellitus in children and adolescents
  Special Issue on Consensus Statements on Insulin Therapy[@ref21]                                                                                                                 2014   Special         API                                                                                                               Diabetes
  National Guidelines for Diagnosis and Management of Gestational Diabetes Mellitus[@ref22]                                                                                        2014   NM              MoHFW, UNICEF                                                                                                     GDM
                                                                                                                                                                                                                                                                                                                            
  **Neurological diseases**                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                            
  Clinical Practice Guidelines for The Management of Depression[@ref23]                                                                                                            2004   NM              IPS guideline committee on depression                                                                             Depression
  Clinical Practice Guidelines for the Management of Schizophrenia[@ref24]                                                                                                         2004   NM              IPS guideline committee on schizophrenia                                                                          Schizophrenia
  Guidelines for The Treatment of Sleep Disorders[@ref25]                                                                                                                          2006   NM              Authors of article                                                                                                Sleep disorders
  Clinical Practice Guidelines for Treatment of Depression In Elderly[@ref26]                                                                                                      2007   NM              Authors of article                                                                                                Depression in elderly
  Clinical Practice Guidelines for The Management of Reversible Dementias[@ref27]                                                                                                  2007   NM              Authors of article                                                                                                Reversible dementias
  Clinical Practice Guidelines for Treatment of Vascular Dementia[@ref28]                                                                                                          2007   NM              Authors of article                                                                                                Vascular dementia
  Guidelines for Treatment of Epilepsy[@ref29]                                                                                                                                     2008   1^st^           Indian Epilepsy Society, Indian Epilepsy Association                                                              Epilepsy
  Guidelines for Diagnosis and Management of Childhood Epilepsy[@ref30]                                                                                                            2009   1^st^           Indian Academy of Pediatrics                                                                                      Childhood epilepsy
  Stroke management[@ref31]                                                                                                                                                        2011   NM              Authors of article                                                                                                Stroke
  Name of the STG                                                                                                                                                                  Year   Edition         Comes under/developed by                                                                                          Scope of guidelines
                                                                                                                                                                                                                                                                                                                            
  **Non-communicable diseases**                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                            
  Indian Guidelines on the Management of SLE[@ref32]                                                                                                                               2002   NM              Single author article                                                                                             SLE
  Guidelines on the Diagnosis and the Current Management of Headache and Related Disorders[@ref33]                                                                                 2011   NM              Drawn up by neurologists with a special interest in headache                                                      Headache
  Consensus Guidelines on Management of Childhood Convulsive Status Epilepticus[@ref34]                                                                                            2014   NM              Multi-disciplinary Consensus Development Workshop on Management of Status Epilepticus in Children in India        Childhood convulsive status epilepticus
  Guidelines for Pregnancy Care and Management of Common Obstetric Complications by Medical Officers[@ref35]                                                                       2005   NM              MoHFW                                                                                                             Common Obstetric Complications
  National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Disease and Stroke[@ref36]                                                                     2008   NM              NPCDCS, Government of India - WHO Collaborative Programme'                                                        Diabetes, hypertension, hypercholesterolemia, CAD, stroke, cancer
  National Snakebite Management Protocol (India) [@ref37]                                                                                                                          2008   1^st^           Authors                                                                                                           Snakebite
  AIOS Guidelines to Prevent Intraocular Infection[@ref38]                                                                                                                         2009   1^st^           All India Ophthalmological Society and Cipla                                                                      Intraocular infection
  Indian Rheumatology Association Guidelines for the Management of Glucocorticoid-induced Osteoporosis[@ref39]                                                                     2011   NM              Indian Rheumatology Association                                                                                   Glucocorticoid-induced osteoporosis
  Standard Treatment Guideline and Essential Medicine List (for pregnant women)[@ref40]                                                                                            2011   1^st^           NRHM, Health and Family Welfare Department, Government of Odisha                                                  Pregnancy, puerperium and newborn
  Guidelines for the Management of Cataract in India[@ref41]                                                                                                                       2011   1^st^           VISION 2020: The Right to Sight India                                                                             Cataract
  Indian Society of Gastroenterology Consensus on Ulcerative Colitis[@ref42]                                                                                                       2012   NM              Indian Society of Gastroenterology                                                                                Ulcerative colitis
  Indian Chronic Kidney Disease Guidelines[@ref43]                                                                                                                                 2013   2^nd^           Indian CKD Guideline Workgroup, Indian Nephrology Society                                                         CKD
  Indian Guidelines on Hypertension - III[@ref44]                                                                                                                                  2013   3^rd^           CSI, HSI, ICP, ISN, RSSDI and IAD                                                                                 Hypertension
  Consensus and Evidence-Based INOSA Guidelines[@ref45]                                                                                                                            2014   1^st^           MoHFW, AIIMS and Multi-speciality disciplines across India- Public and Private Sectors                            Obstructive sleep apnoea
  Management of Neonatal Cholestasis: Consensus Statement of the Pediatric Gastroenterology Chapter of Indian Academy of Pediatrics[@ref46]                                        2014   NM              Indian Academy of Pediatrics                                                                                      Neonatal cholestasis
  Guidelines for treatment of recurrent or metastatic head and neck cancer[@ref47]                                                                                                 2014   NM              ICON                                                                                                              Recurrent or metastatic head and neck cancer
  Guidelines for Diagnosis and Management of Chronic Obstructive Pulmonary Disease[@ref48]                                                                                         2014   Special         Indian Chest Society and National College of Chest Physicians (India)                                             COPD
                                                                                                                                                                                                                                                                                                                            
  **Infectious diseases**                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                            
  IAP Guidelines 2006 on Management of Acute Diarrhea[@ref49]                                                                                                                      2006   1^st^           The Indian Academy of Pediatrics                                                                                  Acute diarrhoea
  Endocrine Society of India Management Guidelines for Patients with Thyroid Nodules: A position statement[@ref50]                                                                 2011   NM              Endocrine Society of India                                                                                        Thyroid nodules
  Revised Statement on Management of Urinary Tract Infections[@ref51]                                                                                                              2011   NM              Indian Society of Pediatric Nephrology                                                                            Urinary tract infections
  Guidelines for Diagnosis and Management of Community and Hospital-Acquired Pneumonia in Adults: Joint ICS/NCCP (I) Recommendations[@ref52]                                       2012   NM              ICS and NCCP                                                                                                      Pneumonia
  Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India[@ref53]   2014   NM              INASL                                                                                                             HCV infection
                                                                                                                                                                                                                                                                                                                            
  **National Health Programmes**                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                            
  National Guidelines on Prevention, Management, and Control of Reproductive Tract Infections including Sexually Transmitted Infections[@ref54]                                    2007   NM              MoHFW, NACO, WHO, UNFPA                                                                                           RTI, STI
  Guidelines for Filariasis elimination in India[@ref55]                                                                                                                           2009   NM              NVBDCP, MoHFW                                                                                                     Filariasis
  National Leprosy Eradication Program, Disability Prevention and Medical Rehabilitation - Guidelines for Primary, Secondary and Tertiary Level Care[@ref56]                       2012   NM              MoHFW, NLEP                                                                                                       Leprosy
  Guidelines for Diagnosis and Treatment of Malaria in India[@ref57]                                                                                                               2013   NM              NVBDCP, National Institute of Malaria Research, MoHFW                                                             Malaria
  ART guidelines for HIV-Infected Adults and Adolescents[@ref58]                                                                                                                   2013   NM              MoHFW, NACO                                                                                                       AIDS
  National Programme for Prevention and Control of Japanese Encephalitis/Acute Encephalitis Syndrome[@ref59]                                                                       2014   NM              NVBDCP, Government of India, Ministry of Health & Family Welfare                                                  JE-AES
  Operational Guidelines on Kala-azar (visceral leishmaniasis) Elimination in India[@ref60]                                                                                        2015   NM              NVBDCP, 'WHO India, RMRI (ICMR) Patna, NCDC, Patna, BMGF/CARE India/DNDi/KalaCORE/PATH'                           Kala-Azar (Visceral Leishmaniasis)
  Standards for TB Care in India[@ref61]                                                                                                                                           2014   NM              MoHFW, The national TB institutions, RNTCP, WHO                                                                   TB
  National Guidelines for Clinical Management of Dengue Fever[@ref62]                                                                                                              2015   NM              NVBDCP, WHO, MoHFW                                                                                                Dengue
  National Guidelines on Rabies Prophylaxis[@ref63]                                                                                                                                2015   2^nd^           National Centre for Disease Control                                                                               Rabies
  Diagnosis and Treatment of Kala-azar[@ref64]                                                                                                                                     NM     NM              MoHFW, NVBDCP                                                                                                     Kala-azar
                                                                                                                                                                                                                                                                                                                            
  **STGs for multiple conditions/speciality**                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                            
  Standard Treatment Guidelines[@ref65]                                                                                                                                            NM     NM              MoHFW                                                                                                             Multiple conditions
  Standard Treatment Guidelines for Medical Officers[@ref66]                                                                                                                       2003   1^st^           Government of Chhattisgarh, Department of Health and Family Welfare, State Health Resource Centre, Chhattisgarh   Multiple conditions
  Standard Treatment Guidelines (medical management and costing of select conditions)[@ref67]                                                                                      2007   NM              MoHFW, AFMC, WHO                                                                                                  Multiple conditions
  Standardisation Initiatives By The FICCI Health Insurance Group[@ref68]                                                                                                          2009   NM              FICCI                                                                                                             Multiple conditions
  Standard Treatment Guidelines A Manual for Medical Practitioners[@ref69]                                                                                                         2010   1^st^           TNHSP, Health and Family Welfare Department, Government of Tamil Nadu                                             Multiple conditions
  Rajasthan State Standard Treatment Guidelines[@ref70]                                                                                                                            2012   2^nd^ special   Rajasthan Medical Services Corporation, DSPRUD                                                                    Multiple conditions
  Manual of Standard Treatment Guidelines Haryana[@ref71]                                                                                                                          2013   Special         NRHM, DSPRUD                                                                                                      Multiple conditions
  ICMR Guidelines[@ref72]                                                                                                                                                          2010   NM              ICMR                                                                                                              Multiple conditions
  Standard Treatment Guidelines A Manual for Medical Therapeutics[@ref73]                                                                                                          2013   1^st^           Gujarat Medical Services Corporation Limited, Health and Family Welfare Department, Government of Gujarat         Multiple conditions
  Standard Treatment Guidelines 2014[@ref74]                                                                                                                                       2014   1^st^           Department of Public Health and Family Welfare, Madhya Pradesh                                                    Multiple conditions

NM, not mentioned; MoHFW, Ministry of Health & Family Welfare; AFMC, Armed Forces Medical College; TNHSP, Tamil Nadu Health Systems Project; ICMR, Indian Council of Medical Research; IAP, The Indian Academy of Pediatrics; NACO, National AIDS Control Organization; RNTCP, Revised National Tuberculosis Control Programme; API, The Association of Physicians of India; AIIMS, All India Institute of Medical Sciences; NLEP, National Leprosy Eradication Programme; NVBDCP, National Vector Borne Disease Control Programme; UNFPA, United Nations Population Fund; CSI, Cardiological Society of India; HSI, Hypertension Society of India; ICP, Indian College of Physicians; ISN, Indian Society of Nephrology; RSSDI, Research Society for Study of Diabetes in India; IAD, Indian Academy of Diabetes; NRHM, National Rural Health Mission; DSPRUD, Delhi Society for Promotion of Rational Use of Drugs; RMRI, Rajendra Memorial Research Institute of Medical Sciences; BMGF, Bill and Melinda Gates Foundation; DNDi, Drugs for Neglected Diseases initiative; INASL, Indian National Association for Study of the Liver; FICCI, Federation of Indian Chambers of Commerce; NPCDCS, National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Disease and Stroke; ICS, The Indian Chest Society; NCCP, National College of Chest Physicians; UNICEF, The United Nations Children's Emergency Fund; ICON, Indian Cooperative Oncology Network; ISPAE, Indian Society for Pediatric and Adolescent Endocrinology; AIOS, All India Ophthalmological Society; WHO, World Health Organisation; STGs, standard treatment guidelines; ISPAE, Indian Society for Pediatric and Adolescent Endocrinology; GDM, Gestational Diabetes Mellitus; SLE, Systemic lupus erythematosus; CAD, Coronary artery disease; CKD, Chronic kidney disease; COPD, Chronic Obstructive Pulmonary Disease; RTI, Reproductive Tract Infections; STI, Sexually Transmitted Infections; JE-AES, Japanese Encephalitis - Acute Encephalitis Syndrome; NCDC, National Centre for Disease Control

*Legal framework governing the development of STGs in India*: The Clinical Establishments (Registration and Regulation) Act 2010 (Act)[@ref7] sets out conditions for the registration of clinical establishments. Although the Act itself does not contain a reference to STGs, clause (*iii*) of Rule 9 of the Clinical Establishments (Central Government) Rules 2012 (Rules)[@ref75] requires clinical establishments, as a condition of registration, to ensure compliance with such STGs as may be determined and issued by the Central and State Governments from time to time. Apart from this provision, however, the rules did not prescribe the procedure by which the STGs ought to be framed or the manner in which the power to develop these guidelines ought to be divided between the Central and State Governments. It was important to note that this provision in the Rules only empowered the Central and State Governments to frame STGs and to require compliance with them by clinical establishments as a condition of registration [Table II](#T2){ref-type="table"}. However, the Clinical Establishments Act does not compel the States to develop STGs as it has been adopted only by a few States and Union Territories[@ref7]. This was in contrast to the UK, where section 237 of the Health and Social Care Act 2012[@ref76] read with section 5 of the National Institute for Health and Care Excellence (Constitution and Functions) Regulations 2013[@ref77] making it a function of NICE to give advice or guidance, provide information or make recommendations regarding any stuff associated with the provision of services under the National Health Service (NHS), public health services as well as social care in England. The Act and regulations additionally require NICE to establish procedures for giving such guidance, including a duty to consult persons if considered appropriate[@ref8][@ref11]. In furtherance of these provisions, NICE has developed an established procedure, the key details of which are briefly described below.

###### 

Comparison between legal authority for standard treatment guidelines in UK and India

  Topic                                    UK                                                                                                                                                                                                                            India
  ---------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------
  Designated body for STGs                 NICE (statutory)                                                                                                                                                                                                              NHSRC, as designated by the NHM (non-statutory body)
  Other organizations developing STGs      GAIN, Royal Colleges These are not binding and may be used locally                                                                                                                                                            State governments, ICMR, central and State national programmes and professional organizations
  Is there a binding duty to frame STGs?   Yes, NICE is statutorily required to provide guidance on matters relating to the provision of NHS services, which would include the framing of STGs or clinical guidelines as these are referred to in the UK                 No, central and State governments have the power to issue STGs under the Clinical Establishments (Central Government) Rules
  Are STGs legal binding?                  No, but STGs provide evidence of a 'responsible body of medical opinion'                                                                                                                                                      Yes, clinical establishments must ensure compliance with STGs as a condition of registration
  Procedure for framing of STGs            Topic selection committee, Referral of topics from NHS, England and the Department of Health, Specialist centres frame STG with the involvement of stakeholders and after considering other guidelines, Public consultation   Although the NHSRC is the designated statutory body, no procedure has been prescribed, DSPRUD STG development procedure

NICE, The National Institute for Health and Care Excellence; NHSRC, National Health Systems Resource Center; STGs, standard treatment guidelines; DSPRUD, Delhi Society for Promotion of Rational Use of Drugs; NHM, National Health Mission; ICMR, Indian Council of Medical Research; NHS, National Health Service; GAIN, Guidelines and Audit Implementation Network

Documentation of the development process in the published Indian STGs was not available on Authority websites and in the STGs.

*Development of NICE guidelines*: At NICE, a Topic Selection-Oversight Group considers topics for guideline development and discusses their findings with the NHS and the Department of Health. Thereafter, the NHS and the Department of Health finalize the topic and make a referral for the development of clinical guidelines on the topic in question to NICE[@ref75]. After the topic for framing a guideline is identified, NICE commissions one of its specialist centres to frame a draft of the guideline on such topic[@ref10]. A number of stakeholders, such as manufacturers of medicines or devices related to the guideline topic, providers and commissioners of health services, national organizations representing patients and carers and/or healthcare professionals, statutory organizations, and research organizations that have formed countrywide recognized research connected to the guideline topic, are consulted throughout the development of each guideline[@ref78]. Subsequently, there is at least one public consultation on the draft of a guideline to gauge the comments of stakeholders registered with NICE. The guideline is then signed off for publication by the Guidance Executive of the NICE, following which steps are taken to communicate, disseminate and promote awareness about the guideline[@ref78].

A number of other organizations such as the Guidelines and Audit Implementation Network (GAIN), the Royal Colleges and various professional organizations formulate clinical guidelines in England. While the clinical guidelines framed by NICE are nationally recognized, the ones framed by GAIN, or the Royal Colleges may be recognized and followed locally. There is nothing to suggest that gives precedence to NICE guidelines over those framed by other bodies. In any case, NICE inspects the clinical guidelines framed by other expert bodies as part of the process of developing its own guidelines[@ref78]. This inspection is helpful in determining the effectiveness of the existing clinical guidelines and practices, as well as in collating the opinion of expert bodies on the standardized treatments for various diseases and conditions.

While the clinical guidelines framed by NICE are not legally binding on medical practitioners and service providers, the courts are inclined to view such guidelines as a responsible body of medical opinion[@ref79][@ref80][@ref81][@ref82]. Consequently, practitioners and service providers, who do not adhere to such guidelines, are required to provide a reasonable explanation (which may be a counter medical opinion backed by credible sources) in order to discharge their burden of observing due diligence while exercising their functions.

*STGs*: *United States of America*:STGs or Clinical Practice Guidelines, as these are more commonly known in the USA are framed by a range of groups/organizations, most of which are made publicly available as resources through the website of the National Guideline Clearinghouse (NGC), set up by the Agency for Healthcare Research and Quality (AHRQ)[@ref83]. The AHRQ, as its website (*<https://www.ahrq.gov/cpi/about/profile/index.html>*)[@ref83] states, is \'the lead Federal agency charged with improving the safety and quality of America\'s health care system.\' A wide variety of organizations frame clinical practice guidelines in the US. According to the categories listed on the NGC website, these include academic institutions, disease-specific societies, federal government agencies, hospitals, independent expert panels, professional associations, non-profit organizations, as well as non-U.S. State/local government agencies. Some of these guidelines are rated according to the strength of their recommendations. For instance, ratings may vary from 1A to 2C, with a rating of 1A meaning \'strong recommendation, high-quality evidence\', while a rating of 2C means \'weak recommendation, low-or-very-low-quality evidence\'[@ref83].

In 2011, a report titled \'Clinical Practice Guidelines we Can Trust\' was published by the Institute of Medicine[@ref84]. This recommended eight standards that clinical practice guidelines ought to adhere to in order to considered trustworthy. The report also recommended that the AHRQ would need the NGC to \'provide a clear indication of the extent to which clinical practice guidelines submitted adhere to the standards for trustworthiness\'[@ref85][@ref86].

Discussion {#sec1-4}
==========

Development of STGs in India is done by multiple authorities like Central Government, State Government, Hospitals, professional associations and private organizations. This shows involvement and commitment by healthcare professionals, and Indian authorities regarding the improvement of healthcare of the population. Government has been developing STGs through the National Health Systems Resource Centre (NHSRC) and also as part of National Health Programme with the help of experts for fulfilling the need of the population.

Most of the STGs found in our study covered important sections in the STGs but key problems with STGs in India that our analysis revealed were-multiplicity, paucity of Indian evidence for guidelines, failure to periodically revise guidelines, failure to tailor them according to the level of healthcare, and finally, a lack of wide availability and accessibility. There were multiple STGs for the same conditions which were made by many authorities and professionals. For instance, there were six separate guidelines for diabetes. Multiplicity could be due to different purpose of development of the guidelines for insurance reimbursement, level of care and the scope of the guidelines. This duplication of efforts and time is avoidable by collaboration which will also save scarce resources, funds and experts\' time.

There is a paucity of Indian research for the development of up to date STGs. Indian studies are particularly needed to answer specific research questions relevant to the Indian setting such as, cost of therapy, variation in dose, antimicrobial resistance. Evidence-based medicine has its own limitations as noted in many research articles but these limitations should not deter the authorities from making evidence-based guidelines[@ref87].

None of the STGs mentioned any specific period after which they were revised. Only one STG was updated to a 3^rd^ edition and six were in first or second editions. Utilization of recent systematic reviews and meta-analysis is important to get the highest quality data. Also, a locally produced STGs suing Indian data might improve acceptability than so-called imported/ international guidance[@ref2].

Major obstacles reported in several studies in regular revisions of STGs were the availability of local expertise and a dearth of awareness of the concept and also prescribers\' firmness on the inclusion of out-of-date practices, or of medications by brand names of untested efficacy. Additionally, it was observed that guidelines review groups often were short of time, interest, resources, and skills to collect and analyse every section of evidence, mainly in relation to editorial responsibilities[@ref2].

Many States and authorities in India have been developing different STGs which are not available online. There is a need to ensure that STGs are made freely available online which could help in wider adoption in clinical practice.

Guidelines in India also have a contribution from the Industry, which could be a potential conflict of interest. As noted in a study by Sharma *et al*[@ref88] government and insurance companies using guidelines as a tool of a coercion to limit treatment choices (limiting medicine reimbursement), restraining independence of the practitioner, were perceived as a major barrier in the STG uptake by the physicians. Most respondents in this study did not appreciate the accountability protection offered by the guidelines, which was different from western country reports, where both these aspects (reimbursement limitations and liability perception) act as enablers for STGs.

One of the solutions to the multiplicity of STGs might be to designate a specific authority with the task of developing STGs, preferably by imposing a statutory duty. This duty could be accompanied by enabling rules and regulations describing the procedure for developing STGs, the information that they ought to contain, and methods of dissemination, along the lines of the procedure followed by NICE. This procedure ought to incorporate the requirement of periodic updating. A good quality STG could include points as mentioned in The international Appraisal of Guidelines, Research and Evaluation (AGREE) II checklist[@ref89].

A particularly useful approach to adopt from NICE is making available evidence summaries for unlicensed or off-label medicines. These summaries critically review the strengths and weaknesses of such medicines, but do not constitute formal NICE guidance[@ref9]. STGs that provide physicians with details about the use of off-label medicines would be especially useful for paediatric treatment in India, where there is already widespread off-label use of drugs[@ref90].

When Indian STGs are compared to NICE guidelines, they fall short in many points. NICE guidelines are updated many times every few years depending on the condition, year of revision and revised points are mentioned clearly, diagnostic criteria and drug/ treatment of choice are given, and it is evidence-based with appropriate scientific references mentioned. In USA, there are multiple agencies which frame the STGs and these are grounded on evidence which are of high-quality with level of evidence and class of recommendations mentioned in most of the guidelines. But just like NICE guidelines, STGs in the USA do not mention points about the cost of treatment[@ref91]. Level of healthcare in the STGs is a unique feature to Indian STGs and this does not find a place in NICE guidelines and USA STGs.

Among the major limitations, STGs are often not published in peer-reviewed scientific journals and are often not available online. The process of developing STGs (except the use of evidence base) was not evaluated as this information was not uniformly available.

India demonstrates great regional variation in disease prevalence as well as the kinds of healthcare providers settings and prescribers. The present analysis while appreciating the STGs developed by the government, individuals and professional organizations in India, demonstrated the need for a collaborative and coordinated approach to STG development, with robust consultative mechanisms, sensitivity to local conditions and easy accessibility. An important first step in this regard would be to provide details of well-defined procedures.
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